Developing Treatment, Treatment Validation, and Treatment Scope in the Setting of an Autism Clinical Trial
Abstract
We submitted and received approval for our latest Continuing Review (CR). In addition an amendment was submitted and approved to use AutismMatch to help increase the rate of subject recruitment. We applied for and received an additional 6 month no cost extension to maximize our ability to collect subjects. Task #2 has been completed. We had a significant set back in the beginning of the year for Task #3. Our LC-MSMS suffered a catastrophic failure early in November 2011 and repairs were not finished until January 4, 2012. Upon repair and calibration we resumed optimizing analysis conditions including conditions for three additional isoprostanes. We began Task #4, sample analysis. We completed initial analysis of the first 18 pre and 18 post treatment samples. We will complete Task #4 and once all subjects have finished treatment. Tasks # 5 and 6 will be completed once subject treatment has finished. Please see initiating project W81XWH-08-1-0728 and partnering project W81XWH-08-1-0730.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2012
- Accession Number
- ADA574732
Entities
People
- T. P. Stein
Organizations
- Robert Wood Johnson Medical School